Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03862430 |
|---|---|
| Brief Title: | A Phase II Double-blind, RandomizEd, Prospective, Placebo Controlled STudy of NanO2TM Combined With Radiation and Temozolomide in Patients With Newly-diagnosed Glioblastoma multiformE: (RESTORE) |
| First Submitted : | March 1, 2019 |
| First Submitted that Met QC Criteria : | March 1, 2019 |
| First Posted : | March 5, 2019 |
| Last Update Submitted that Met QC Criteria : | January 23, 2024 |
| Last Update Posted : | January 24, 2024 |